23andMe 
                     , ou la chute d’une licorne 
                     *

Jordan, Bertrand

doi:10.1051/medsci/2024188

dc.contributor.author	Jordan, Bertrand	-
dc.date.accessioned	2026-01-20T16:50:34Z
dc.date.available	2026-01-20T16:50:34Z
dc.date.issued	2025
dc.identifier.citation	Jordan, Bertrand ; 23andMe , ou la chute d’une licorne * , Med Sci (Paris), Vol. 41, N° 1 ; p. 73-76 ; DOI : 10.1051/medsci/2024188
dc.identifier.issn	1958-5381
dc.identifier.uri	http://hdl.handle.net/10608/15290
dc.description.abstract	23andMe, a company pioneering on-demand genetic profiling, has attracted much attention, millions of customers and very significant investments, as well as some lucrative collaborations with the pharmaceutical industry. Yet the company is now in deep trouble, with shares worth pennies, and may go bankrupt in the near future. This article describes the firm’s history and attempts to understand its problems.	en
dc.language.iso	fr
dc.publisher	EDP Sciences
dc.relation.ispartof	Forum
dc.rights	Article en libre accès - License CC BY 4.0	fr
dc.rights	Médecine/Sciences - Inserm - SRMS	fr
dc.rights.uri	http://creativecommons.org/licenses/by/4.0
dc.source	M/S. Médecine sciences [ISSN papier : 0767-0974 ; ISSN numérique : 1958-5381], Vol. 41, N° 1; p. 73-76
dc.subject.mesh	Humains	fr
dc.subject.mesh	Industrie pharmaceutique	fr
dc.subject.mesh	économie	fr
dc.subject.mesh	Histoire du 20ème siècle	fr
dc.subject.mesh	Histoire du 21ème siècle	fr
dc.subject.mesh	Investissements	fr
dc.subject.mesh	économie	fr
dc.title	23andMe , ou la chute d’une licorne *	fr
dc.title.alternative	The fall of an Unicom	en
dc.type	Article
dc.contributor.affiliation	Biologiste, généticien et immunologiste, Président d’Aprogène (Association pour la promotion de la Génomique) , 13007 , Marseille , France
dc.identifier.doi	10.1051/medsci/2024188
dc.identifier.pmid	39887103